Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis

Figure 2

(a)–(i) The positive associations between some risk factors and CIN. HTN, hypertension; DM, diabetes mellitus; PMI, prior myocardial infarction; LAD, left anterior descending; LVEF, left ventricular ejection fraction (%). Crit 1: CIN defined as increase in serum creatinine ≥25%. Crit 2: CIN defined as increase in serum creatinine ≥0.5 mg/dL. Crit 3: CIN defined as increase in serum creatinine of ≥25% or ≥0.5 mg/dL. Crit 4: CIN defined as an increase in serum creatinine >25% or a decrease in the estimated glomerular filtration rate (eGFR) <25%. Crit 5: CIN defined as a rise in serum creatinine >26.5 μmol/L or >50%.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)